Le Gac S - Search Results

1

Metabolic syndrome and endocrine status in HIV-infected transwomen.

Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P. Pommier JD, et al. Among authors: le gac s. AIDS. 2019 Apr 1;33(5):855-865. doi: 10.1097/QAD.0000000000002152. AIDS. 2019. PMID: 30664006

2

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.

Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, Delaugerre C, Morand-Joubert L, Ruffault A, Izopet J, Plantier JC, Pakianather S, Montes B, Chaix ML, Wirden M, Costagliola D, Masquelier B; ANRS AC11 Resistance Group. Assoumou L, et al. J Antimicrob Chemother. 2013 Jun;68(6):1400-5. doi: 10.1093/jac/dkt033. Epub 2013 Feb 12. J Antimicrob Chemother. 2013. PMID: 23404192

3

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.

Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, Yazdanpanah Y. Charpentier C, et al. Among authors: le gac s. PLoS One. 2013;8(3):e59205. doi: 10.1371/journal.pone.0059205. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23527135 Free PMC article.

4

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G; DAYANA Study Group. Lê MP, et al. J Antimicrob Chemother. 2015 May;70(5):1517-21. doi: 10.1093/jac/dku532. Epub 2015 Jan 11. J Antimicrob Chemother. 2015. PMID: 25583749 Clinical Trial.

5

Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G. Lê MP, et al. Antivir Ther. 2015;20(5):507-13. doi: 10.3851/IMP2936. Epub 2015 Jan 20. Antivir Ther. 2015. PMID: 25599649

6

Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R; PARCOURS Study Group. Desgrees-du-Lou A, et al. AIDS. 2016 Feb 20;30(4):645-56. doi: 10.1097/QAD.0000000000000957. AIDS. 2016. PMID: 26558722 Free PMC article.

7

Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.

Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V. Senard O, et al. Among authors: le gac s. AIDS Res Hum Retroviruses. 2017 Jan;33(1):11-16. doi: 10.1089/AID.2016.0036. Epub 2016 Sep 7. AIDS Res Hum Retroviruses. 2017. PMID: 27476681

8

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals.

Unal G, Alessandri-Gradt E, Leoz M, Pavie J, Lefèvre C, Panjo H, Charpentier C, Descamps D, Barin F, Simon F, Meyer L, Plantier JC; ORIVAO Study. Unal G, et al. Clin Infect Dis. 2018 May 17;66(11):1785-1793. doi: 10.1093/cid/cix1087. Clin Infect Dis. 2018. PMID: 29272369

9

High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.

Charpentier C, Peytavin G, Lê MP, Joly V, Cabras O, Perrier M, Le Gac S, Phung B, Yazdanpanah Y, Descamps D, Landman R. Charpentier C, et al. Among authors: le mp, le gac s. J Antimicrob Chemother. 2018 Jun 1;73(6):1665-1671. doi: 10.1093/jac/dky062. J Antimicrob Chemother. 2018. PMID: 29528412

10

Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.

Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E. Couffignal C, et al. AIDS Care. 2020 Jul;32(7):811-817. doi: 10.1080/09540121.2019.1653438. Epub 2019 Aug 21. AIDS Care. 2020. PMID: 31431047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page